Neuronetics Stock (NASDAQ:STIM)

Forecast Revenue Ownership Financials Chart Transcripts

Previous Close

$1.29

52W Range

$0.52 - $5.07

50D Avg

$1.01

200D Avg

$1.95

Market Cap

$44.58M

Avg Vol (3M)

$442.46K

Beta

2.22

Div Yield

STIM Company Profile

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Industry

Medical - Diagnostics & Research

Sector

Healthcare

Exchange

NASDAQ

ADR

Country

Employees

203

IPO Date

Jun 28, 2018

Website

STIM Performance

STIM Financial Summary

	Dec 23	Dec 22	Dec 21
Revenue	$71.35M	$65.21M	$55.31M
Operating Income	$-30.55M	$-35.11M	$-27.56M
Net Income	$-30.19M	$-39.21M	$-35.60M
EBITDA	$-30.55M	$-31.26M	$-26.11M
Basic EPS	$-1.05	$-1.46	$-1.40
Diluted EPS	$-1.05	$-1.46	$-1.40

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts

Q3 24Nov 12, 24 | 8:41 PM

Q2 24Aug 12, 24 | 1:59 PM

Q1 24May 07, 24 | 12:00 AM

Peer Comparison

Ticker	Company
SERA	Sera Prognostics, Inc.
ENZ	Enzo Biochem, Inc.
DRIO	DarioHealth Corp.
BDSX	Biodesix, Inc.
XGN	Exagen Inc.
BNR	Burning Rock Biotech Limited
FONR	FONAR Corporation
SHC	Sotera Health Company